Kangmei Pharma | 600518 - Pre Tax Profit

Stock Price
1.93
Daily Change
0.02 1.05%
Monthly
0.52%
Yearly
-9.39%
Q1 Forecast
1.85

Kangmei Pharma reported CNY2.07M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -23.77M 12.2M Jun/2025
Cspc Pharmaceutical CNY 1.21B 110.04M Sep/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Genomma Lab Internacional MXN 607.56M 50.72M Sep/2025
Hypermarcas BRL 448.11M 14.12M Sep/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
IQVIA Holdings USD 6.16B 5.84B Sep/2025
Jiangsu Hengrui CNY 1.36B 1.61B Sep/2025
Kangmei Pharma CNY 2.07M 13.77M Sep/2025
Moderna USD -187M 631M Sep/2025
Organon & Co USD 243M 14M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Sh Fosun Pharma CNY 1.12B 252.08M Sep/2025
Tectonic Therapeutic USD -19.04M 25K Sep/2025
Viatris USD -7.9M 209.2M Sep/2025
Wuxi Apptec CNY 5.03B 595.17M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025
Zz Pientze Pharmaceu CNY 523.11M 659.54M Jun/2025